期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
基于代谢分型的肿瘤生酮治疗敏感性及机制研究进展
1
作者 唐蒙 周福祥 +1 位作者 丛明华 石汉平 《肿瘤代谢与营养电子杂志》 2023年第4期482-486,共5页
能量代谢异常是肿瘤的基本特征之一。尽管靶向肿瘤代谢是一项公认的治疗策略,但临床治疗成功取决于准确的代谢分子分型。近期研究报道了肿瘤生酮治疗相关的两种代谢亚型:糖酵解型和酮体代谢型,两者表现为完全不同的代谢酶谱和线粒体功... 能量代谢异常是肿瘤的基本特征之一。尽管靶向肿瘤代谢是一项公认的治疗策略,但临床治疗成功取决于准确的代谢分子分型。近期研究报道了肿瘤生酮治疗相关的两种代谢亚型:糖酵解型和酮体代谢型,两者表现为完全不同的代谢酶谱和线粒体功能状态,以及在体外和体内对生酮干预的不同反应。同时,在p53突变的肿瘤中,糖酵解亚型在葡萄糖限制的状态下可转变为酮体代谢型,随着酮体酶的表达激活及线粒体融合,出现生酮治疗抵抗。通过联用突变p53的变构激活剂,将突变的p53变成野生型的构象,可逆转酮体酶表达激活及线粒体代谢重编,保持稳定的酮体代谢缺陷表型。基于代谢亚型可以选择肿瘤生酮治疗的目标人群,通过基因突变状态可预测生酮治疗敏感性,从而建立精准肿瘤代谢调节治疗策略。 展开更多
关键词 肿瘤生酮治疗 代谢分型 糖酵解 酮体分解酶 P53
下载PDF
药物代谢分型的研究进展 被引量:11
2
作者 周权 姚彤炜 曾苏 《中国现代应用药学》 CAS CSCD 2000年第6期423-429,共7页
目的 :为了促进药物代谢分型研究在临床上的深入。方法 :综述近几年具遗传多态性代谢酶的探针药物、代谢分型方法以及影响因素。介绍“Cocktail”分型法。比较代谢分型与基因分型两种分型方法。结果 :疾病、并用药物、探药剂量、样本处... 目的 :为了促进药物代谢分型研究在临床上的深入。方法 :综述近几年具遗传多态性代谢酶的探针药物、代谢分型方法以及影响因素。介绍“Cocktail”分型法。比较代谢分型与基因分型两种分型方法。结果 :疾病、并用药物、探药剂量、样本处理方法、服药依从性是代谢分型的主要影响因素。结论 :药物代谢分型能指导临床安全合理有效地用药。基因分型与代谢分型各有优缺点 ,应灵活应用。“Cocktail”分型方法具有独特的优越性和发展前景。 展开更多
关键词 代谢 遗传多态性 代谢分型 基因分型
下载PDF
手性毛细管色谱法测定人尿中美芬妥英对映体的含量及其在代谢分型中的应用 被引量:4
3
作者 姚彤炜 曾苏 +1 位作者 阮宏强 陈枢青 《色谱》 CAS CSCD 北大核心 1998年第5期408-410,共3页
采用手性毛细管色谱柱和FID检测器建立了人尿中美芬妥英(MP)对映体的定量分析方法。尿样用二氯乙烷提取,用酸、碱洗涤得以纯化,测得各对映体的最低检测限为60μg/L。在115~690μg/L浓度范围内,标准曲线呈良好... 采用手性毛细管色谱柱和FID检测器建立了人尿中美芬妥英(MP)对映体的定量分析方法。尿样用二氯乙烷提取,用酸、碱洗涤得以纯化,测得各对映体的最低检测限为60μg/L。在115~690μg/L浓度范围内,标准曲线呈良好的线性关系,r>0.99,日内、日间精密度RSD<6.5%,S-MP的平均回收率为74.41%,R-MP的平均回收率为73.78%。并以MP为探针药物,对32名志愿者的尿样进行了MP氧化代谢分型研究。 展开更多
关键词 手性毛细管色谱 美芬妥英 代谢分型 尿液 分析
下载PDF
汉族、哈萨克族113例乙酰化代谢分型调查
4
作者 陈春雁 陈艳芬 +2 位作者 邹玉萍 李翰章 尚玉红 《石河子医学院学报》 1989年第4期199-200,共2页
某些药物在体内乙酰化代谢呈多型性。调查和测定群体和个体的乙酰化代谢分型对给药方案的个体化有重要意义。本调查参照曾氏失活指数法对新疆汉族、哈萨克族人群服用异烟肼作乙酰化代谢分型调查。共调查113例,其中汉族38例,慢型占18.4%... 某些药物在体内乙酰化代谢呈多型性。调查和测定群体和个体的乙酰化代谢分型对给药方案的个体化有重要意义。本调查参照曾氏失活指数法对新疆汉族、哈萨克族人群服用异烟肼作乙酰化代谢分型调查。共调查113例,其中汉族38例,慢型占18.4%;哈萨克族75例,慢型占56.0%,经 X^2分析 P<0.005,两者差异非常显著。本文对负值和中间值出现的原因进行探讨,在统计中和给药方案的设计时提出自已的处理意见。 展开更多
关键词 乙酰化代谢 异烟肼 代谢分型
下载PDF
弥漫性大B细胞淋巴瘤的能量代谢分型及研究进展 被引量:1
5
作者 龚鑫 龚钰淇 +2 位作者 丁利雅 雷丽珍 周韧 《中华病理学杂志》 CAS CSCD 北大核心 2019年第1期63-66,共4页
弥漫性大B细胞淋巴瘤(diffuse large Bcell lymphoma,DLBCL)是一种具有高度异质性的侵袭性恶性肿瘤,这种异质性不仅表现在临床结局、遗传特征、细胞起源等方面,而且在能量代谢方面也存在着明显的异质性。根据能量代谢差异,DLBCL可分为... 弥漫性大B细胞淋巴瘤(diffuse large Bcell lymphoma,DLBCL)是一种具有高度异质性的侵袭性恶性肿瘤,这种异质性不仅表现在临床结局、遗传特征、细胞起源等方面,而且在能量代谢方面也存在着明显的异质性。根据能量代谢差异,DLBCL可分为以有氧糖酵解为主要代谢特征的B细胞受体(BCR)-DLBCL亚型和以氧化磷酸化(OxPhos)为主要代谢特征的OxPhos-DLBCL亚型。对于这两种不同代谢方式的DLBCL,有着差异显著的细胞调控通路。目前研究表明,BCR信号通路、bcl-6和自噬等调节BCR-DLBCL亚型细胞的有氧糖酵解过程;高度活化的线粒体功能基因和高表达的脂肪酸代谢关键基因等调节OxPhos-DLBCL亚型细胞的氧化磷酸化过程。靶向DLBCL的能量代谢差异及相关调控通路,可能为DLBCL患者的治疗和预后评估提供新的思路。 展开更多
关键词 弥漫性大B细胞淋巴瘤 能量代谢 代谢分型 DLBCL LYMPHOMA 氧化磷酸化 有氧糖酵解 信号通路
原文传递
新疆汉族和维吾尔族人群乙酰化代谢分型调查分析
6
作者 尚玉红 王文捷 《首都医药》 2005年第10期44-44,共1页
目的由遗传因素决定的某些药物在体内乙酰化代谢呈多型性,即快型和慢型之分。采取同样给药方案,人群间疗效和毒性差异很大。通过测定人群间乙酰化代谢分型,对给药方案个体化,使用药物安全有效,乃至指导新药设计都有重要意义。方法用失... 目的由遗传因素决定的某些药物在体内乙酰化代谢呈多型性,即快型和慢型之分。采取同样给药方案,人群间疗效和毒性差异很大。通过测定人群间乙酰化代谢分型,对给药方案个体化,使用药物安全有效,乃至指导新药设计都有重要意义。方法用失活指数法对新疆汉族、维吾尔族人群服用异烟肼作乙酰化代谢分型调查。结果共调查68例,其中汉族38例,慢型占18.4%,维吾尔族30例,慢型占50%,经X分析P<20.01。结论两者差异非常显著。对负值和中间值出现的原因进行探讨,在统计中和给药方案设计时提出自己的处理意见。 展开更多
关键词 乙酰化代谢 维吾尔族 分型调查 人群 汉族 新疆 给药方案 遗传因素 代谢分型 药物安全 重要意义 新药设计 处理意见 多型性 慢型 性差异 个体化 指数法 异烟肼 X^2
原文传递
吸烟对药物的影响
7
作者 牛其昌 《青岛医药卫生》 1995年第10期37-38,共2页
吸烟不仅损害心血管、呼吸、神经、消化等脏器,诱发相应的疾病,且影响胎儿的发育。近年来,有关吸烟引起药物动力学和药效学改变的报告骤增。有学者提出,所有临床药学研究报告中,均应报告或充分考虑受试者吸烟的情况。有人做阿米替林对... 吸烟不仅损害心血管、呼吸、神经、消化等脏器,诱发相应的疾病,且影响胎儿的发育。近年来,有关吸烟引起药物动力学和药效学改变的报告骤增。有学者提出,所有临床药学研究报告中,均应报告或充分考虑受试者吸烟的情况。有人做阿米替林对异喹胍遗传与代谢分型的相关性研究时,受试者包括了4名吸烟者,使阿米替林清除增快,破坏了线性相关,几乎歪曲了试验的结果和结论。 吸烟可引起不少药物的代谢增快、作用减弱。 展开更多
关键词 非吸烟者 茶碱 清除率 药物不良相互作用 血药浓度 美西律 阿米替林 不吸烟者 心得安 代谢分型
下载PDF
The exciting and magical journey of components from compound formulae to where they fight 被引量:3
8
作者 Ning Meng Yun Lyu +3 位作者 Xiaoyu Zhang Xin Chai Kefeng Li Yuefei Wang 《Acupuncture and Herbal Medicine》 2022年第4期240-252,共13页
With its long-term empirical clinical practice and increasing number of health benefits reported,Chinese Materia Medica(CMM)is gaining increasing global acceptance.Importantly,the identification of chemical constituen... With its long-term empirical clinical practice and increasing number of health benefits reported,Chinese Materia Medica(CMM)is gaining increasing global acceptance.Importantly,the identification of chemical constituents in vitro and exposed forms in vivo is a prerequisite for understanding how CMM formulae prevent and treat diseases.This review systematically summarizes the exciting and magical journey of CMM components from compound formulae to where they fight,the possible structural transformation of CMM components in vitro and in vivo,and their pharmacological contribution.When a decoction is prepared,significant chemical reactions are observed,including degradation and production of polymers and self-assembling supramolecules,leading to the construction of a component library with diverse decoction structures.After ingestion,compounds pass through the intestinal and blood-brain barriers and undergo a more wonderful journey involving the gut microbiota,microbial enzymes,and endogenous drug-metabolizing enzymes(mainly liver enzymes).At this stage,they are modified and assembled into novel and complex compounds,such as newly generated metabolites,conjugates,and self-assembling superamolecules.This review might provide a strategic orientation to explore the active compounds of CMM formulae in vivo. 展开更多
关键词 Chinese Material Medica FORMULAE Gut microbiota Metabolites Prototype components Self-assembling supramolecule
下载PDF
Way back for fructose and liver metabolism:Bench side to molecular insights 被引量:2
9
作者 Alba Rebollo Núria Roglans +1 位作者 Marta Alegret Juan C Laguna 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第45期6552-6559,共8页
The World Health Organization recommends that the daily intake of added sugars should make up no more than 10% of total energy.The consumption of sugarsweetened beverages is the main source of added sugars.Fructose,to... The World Health Organization recommends that the daily intake of added sugars should make up no more than 10% of total energy.The consumption of sugarsweetened beverages is the main source of added sugars.Fructose,together with glucose,as a component of high fructose corn syrups or as a component of the sucrose molecule,is one of the main sweeteners present in this kind of beverages.Data from prospective and intervention studies clearly point to high fructose consumption,mainly in the form of sweetened beverages,as a risk factor for several metabolic diseases in humans.The incidence of hypertension,nonalcoholic fatty liver disease(NAFLD),dyslipidemia(mainly hypertriglyceridemia),insulin resistance,type 2 diabetes mellitus,obesity,and the cluster of many of these pathologies in the form of metabolic syndrome is higher in human population segments that show high intake of fructose.Adolescent and young adults from lowincome families are especially at risk.We recently reviewed evidence from experimental animals and human data that confirms the deleterious effect of fructose on lipid and glucose metabolism.In this present review we update the information generated in the past 2 years about high consumption of fructose-enriched beverages and the occurrence of metabolic disturbances,especially NAFLD,type 2 diabetes mellitus,and metabolic syndrome.We have explored recent data from observational and experimental human studies,as well as experimental data from animal and cell models.Finally,using information generated in our laboratory and others,we provide a view of the molecular mechanisms that may be specifically involved in the development of liver lipid and glucose metabolic alterations after fructose consumption in liquid form. 展开更多
关键词 OBESITY Metabolic syndrome HYPERTENSION DYSLIPIDEMIA Nonalcoholic fatty liver disease Clinicalstudies Experimental studies Sweetened beverages
下载PDF
绍兴地区25132例育龄妇女血浆Hcy浓度检测及高Hcy育龄妇女叶酸代谢基因检测分析 被引量:3
10
作者 周峰英 沈秋红 孙红娥 《中国优生与遗传杂志》 2014年第8期59-60,58,共3页
目的调查分析绍兴地区育龄妇女血浆同型半胱氨酸(Hcy)浓度及叶酸代谢基因分型情况。方法对绍兴地区25132例育龄妇女血浆Hcy浓度的进行检测,对检测到的同型半胱氨酸(Hcy)高于正常参考范围的妇女进行叶酸代谢通路4个关键酶的基因进行分型... 目的调查分析绍兴地区育龄妇女血浆同型半胱氨酸(Hcy)浓度及叶酸代谢基因分型情况。方法对绍兴地区25132例育龄妇女血浆Hcy浓度的进行检测,对检测到的同型半胱氨酸(Hcy)高于正常参考范围的妇女进行叶酸代谢通路4个关键酶的基因进行分型。结果绍兴地区育龄妇女血浆Hcy平均浓度为(8.0±3.81μmol/L),且随着年龄增长而升高。高龄组(>41岁)高Hcy血症(>15μmol/L)的检出率显著高于低年龄组(<21岁),P<0.05。结论绍兴地区育龄妇女血浆Hcy浓度总体保持在一个合理的水平。通过对高Hcy血症育龄妇女的叶酸代谢通路四个关键酶的基因检测分型,有利于全面掌握育龄妇女机体内叶酸代谢情况,为个性化补充叶酸提供科学依据,从而最大程度降低出生缺陷的发生。 展开更多
关键词 育龄妇女 同型半胱氨酸 叶酸代谢基因分型
原文传递
Comparison of efficacy of treating obese patients with endocrine-metabolic abnormity by electroacupuncture of different types of wave modes 被引量:3
11
作者 刘运珠 粟胜勇 +8 位作者 潘秋兰 宁发锦 李家言 陈丹丹 梁静 罗宇 黎光辉 周云芝 吴文芬 《World Journal of Acupuncture-Moxibustion》 2014年第3期1-8,共8页
Objective To compare the efficacy of treating obese patients with abnormity of lipids and serum leptin by dilatational wave or continuous wave of electroacupuncture combined with thunder-fire moxibustion in order to p... Objective To compare the efficacy of treating obese patients with abnormity of lipids and serum leptin by dilatational wave or continuous wave of electroacupuncture combined with thunder-fire moxibustion in order to provide a clinical basis for selecting wave types of electroacupuncture for different patterns of obesity. Methods Sixty obese patients with abnormal lipids and serum leptin were randomly divided into a dilatational wave group and a continuous wave group via random number table, with 30 cases in each group. They were divided by TCM differentiation into three types: stomachintestine excessive heat, weakness of the spleen-stomach and spleen-kidney yang deficiency, treated by electroacupuncture on Tianshu (天枢 ST 25), Daheng (大横 SP 15), Zusanli (足三里ST 36), Shangjuxu (上巨虚 ST 37), Fanglong (丰隆 ST 40), Yinlingquan (阴陵泉 SP 9), Quchi (曲池 LI 11), Zhigou (支沟 TE 6) and Hegu (合谷 LI 4) along with thunder-fire moxibustion. The frequency of electro-acupuncture in the dilatational wave group and the continuous wave group was 2 Hz/100 Hz and 2 Hz, respectively. Patients in the two groups were treated once a day, six times a week. The treatment lasted for 4 weeks with 3-month follow-up. Body mass and body fat percentage before and after the treatment, as well as during the follow-up, were compared. The effectiveness rates in the two groups were compared, and the efficacy statistics of patients with different TCM patterns in the dilatational wave group were also analyzed. Lipid levels of the patients in two groups before and after the treatment were measured with an automatic biochemical analyzer, and serum leptin levels were detected with flow cytometry system. Results After the treatment, the patients' blood lipids, serum leptin levels, body mass and body fat percentage were effectively reduced in the two groups; three months' follow-up witnessed continuous decline of obesity indicators (P〈0.01 or P〈0.05), and patients in the dilatat-ional wave group improved more significantly than those in continuous wave group (P〈0.05 or P〈0.01). The efficacy in the dilatational wave group was superior to that in the continuous wave group (P〈0.01). The best efficacy could be found among patients with weakness of the spleen and the stomach in the dilatational wave group. Conclusion Efficacy of treating obese patients with abnormity of lipids and serum leptin by electro-acupuncture combined with thunder-fire moxibustion in the dilatational wave group was significantly better than that of the continuous wave group, and efficacy for obese patients with weakness of the spleen and the stomach was superior to that of those with stomach-intestine excessive heat and spleen-kidney yang deficiency. 展开更多
关键词 obesity with metabolic abnormalities pattern differentiation acupuncture therapy electro-acupuncture wave types thunder-fire moxibustion
原文传递
Recent advance in SNP identifying methods and individualized medication 被引量:2
12
作者 彭锐 张洪 张英 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2014年第10期731-738,共8页
Polymorphisms associated with genes coding for a variety of drug-metabolizing enzymes (DMEs) and associated transport proteins can influence the drug metabolism rate of individuals, potentially affecting the efficac... Polymorphisms associated with genes coding for a variety of drug-metabolizing enzymes (DMEs) and associated transport proteins can influence the drug metabolism rate of individuals, potentially affecting the efficacy of drug and the occurrence of adverse reactions. Single nucleotide polymorphisms (SNPs) are prevalent in all types of genetic variations. Reliable SNP genotyping provides excellent markers for detecting genetic polymolphisms, genetic disorders, and resistance of pathogen to drug, which are needed for the genetic diagnosis of disease and subtle genetic factors. With a large number of SNP genotyping studies being conducted, a lot of novel SNP identifying methods have been developed. Several SNP genotyping methods and techniques have been introduced for clinical test. These include TaqMan drug metabolism genotyping assays, pH-sensing semiconductor system, high-resolution melting curve analysis (HRM) of polymerase chain reaction (PCR) amplicons, novel multiplexed electrochemical biosensor with non-fouling surface, DNA hybridization detection using less than 10-nm gap silicon nanogap structure, tetra-primer ARMS-PCR method, acoustic detection of DNA conformation in genetic assays combined with PCR, microbeads-mass spectrometry (MEMS)-based approach, and liquid chromatography-electrospray ionization mass spectrometry. Personalized medicine has changed the conventional ways of using drugs according to experiences. It focuses on making the individualized pattern for each individual based on their own characteristics. Lots of researchers are using the analysis of clinical samples to explain the relationship between the drug adverse reactions and genetic polymorphisms. But it takes a long time from collecting the blood samples for DNA extraction and genotyping to getting results on the side effect of drug through clinical study. Therefore, it is desirable to develop improved in vitro methods to study the drug metabolizing-enzymes and transport protein genetic polymorphisms. 展开更多
关键词 Single nucleotide polymorphism GENOTYPING Drug-metabolizing enzymes Transporters PHARMACOGENOMICS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部